Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-415-9 | CAS number: 15396-00-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No specific test data for skin sensitisation are available for the registered substance, 3-(trimethoxysilyl)propyl isocyanate. However, isocyanates are known skin sensitisers with many references in the open literature (see for example HSDB database). It is therefore reasonable to conclude that 3-(trimethoxysilyl)propyl isocyanate could cause skin sensitisation.
There is good evidence to indicate that isocyanates: cause chemical bronchitis/pneumonitis; are potent pulmonary sensitizers capable of causing “isocyanate asthma”; cause nonspecific airways disease, including chronic bronchitis; can induce a general asthmatic state; and can cause hypersensitivity pneumonitis. Similar dose-response relationships are seen for both acute and chronic effects (Musk et al., 1988).
Reference
Musk et al., 1988. American Journal of Industrial Medicine, Vol 13, Issue 3, pages 331-349
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Isocyanates cause asthma. The symptoms of asthma include coughing, shortness of breath, wheezing, and chest tightness. Symptoms can occur soon after exposure or several hours later. Isocyanates can also cause hypersensitivity pneumonitis, a lung disease whose symptoms include fever, body aches, shortness of breath, and cough with phlegm or sputum. About one out of twenty people who work with isocyanates becomes "sensitized" to them. Being "sensitized" to isocyanates means that you may have an asthma attack any time you are exposed to them, even to extremely small amounts. Sensitivity to isocyanates can be permanent. Also, continuing to work with isocyanates after you become sensitized can cause asthma itself to become permanent, so that attacks can occur even without any further exposure to isocyanates. Once you become sensitized, you cannot continue to work in any job where you could be exposed to isocyanates. You can become sensitized to isocyanates without ever having had any other symptoms of overexposure. There is no evidence that people with other allergies are more likely to become sensitized to isocyanates. Daily exposure to levels of isocyanates too low to sensitize you or cause asthma or pneumonitis may still cause a reduction in lung capacity and function ((http://www.cdph.ca.gov/programs/hesis/Documents/iso.pdf).
Skin sensitisation data for the hydrolysis product, 3-(trimethoxysilyl)propylamine (CAS 13822-56-5), have been added to the dataset as supporting information. The skin and respiratory sensitisation are determined by the isocyanate group. The hydrolysis product data support this conclusion as the skin sensitisation test does not lead to classification for skin sensitisation for the hydrolysis product, which lacks an isocyanide group. Therefore, supports the use of OEL for isocyanates for DNEL derivation.
Justification for classification or non-classification
Based on data for isocyanates, 3-(trimethoxysilyl) isocyanate is classified for skin sensitisation Cat. 1A and respiratory sensitisation Cat. 1 with hazard statements 'H317: May cause an allergic skin reaction' and 'H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled' according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
